Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00VLQ
|
|||
Drug Name |
Hydroxyqunoline analog 1
|
|||
Synonyms |
PMID25468267-Compound-41
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C10H7NO3
|
|||
Canonical SMILES |
C1=CC2=C(C=CC(=C2N=C1)O)C(=O)O
|
|||
InChI |
1S/C10H7NO3/c12-8-4-3-7(10(13)14)6-2-1-5-11-9(6)8/h1-5,12H,(H,13,14)
|
|||
InChIKey |
JGRPKOGHYBAVMW-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5852-78-8
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:93239
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lysine-specific demethylase 4E (KDM4E) | Target Info | Inhibitor | [1] |
Target's Patent Info | Lysine-specific demethylase 4E (KDM4E) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.